Business
Appointment of Aquis Corporate Adviser
ProBiotix Health PLC announced the appointment of AlbR Capital Limited as its Aquis Corporate Adviser, effective immediately on October 23, 2025. The company, which focuses on developing probiotics to support cardiometabolic health, is listed on AQSE under the ticker PBX. This appointment is intended to bolster ProBiotix's corporate advisory resources as it continues its work in microbiome modulating probiotics. Disclaimer*
About this update from Probiotix Health Plc
23 October 2025 ProBiotix Health plc ("ProBiotix" or the "Company" or, together with its subsidiary, the "Group") Appointment of Aquis Corporate Adviser ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that AlbR Capital Limited has been appointed as Aquis Corporate Adviser to the Company with immediate effect. For further information, please contact: ProBiotix Health plc https://probiotixhealth-ir.com/ [email protected] Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations AlbR Capital Limited Aquis Corporate Adviser and Broker Tel: 020 7469 0930 Notes to Editors: ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals. The Company has a singular approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.
View stock analysis, news, and events for Probiotix Health Plc